Alnylam Pharmaceuticals Inc (ALNY)
277.35
+5.13
(+1.88%)
USD |
NASDAQ |
Nov 08, 16:00
277.35
0.00 (0.00%)
After-Hours: 20:00
Alnylam Pharmaceuticals Research and Development Expense (% of Annual Revenues)
Research and Development Expense (% of Annual Revenues) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Research and Development Expense (% of Annual Revenues) Data
| Date | Value |
|---|---|
| December 31, 2023 | -- |
| December 31, 2022 | -- |
| December 31, 2021 | -- |
| December 31, 2020 | -- |
| December 31, 2019 | -- |
| December 31, 2018 | -- |
| December 31, 2017 | -- |
| December 31, 2016 | -- |
| December 31, 2015 | -- |
| December 31, 2014 | -- |
| December 31, 2013 | -- |
| Date | Value |
|---|---|
| December 31, 2012 | -- |
| December 31, 2011 | -- |
| December 31, 2010 | -- |
| December 31, 2009 | -- |
| December 31, 2008 | -- |
| December 31, 2007 | -- |
| December 31, 2006 | -- |
| December 31, 2005 | -- |
| December 31, 2004 | -- |
| December 31, 2003 | -- |
R&D Expense Definition
R&D expense is a line item from many companies' income statements.